Cases & Deals

GenScript Bio's non-wholly-owned subsidiary Probio Technology Limited raises $37 million in Series B financing

Clients GenScript Biotech Corporation

Jones Day represented GenScript Biotech Corporation (HK Stock Code: 1548) ("GenScript Biotech") in the $37 million Series B financing of non-wholly-owned subsidiary Probio Technology Limited ("Probio Cayman"), led by Zhenjiang High-tech Venture Capital (HK) Limited.